Stock Information
Nektar Therapeutics (NKTR)
Ticker Symbol: NKTR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,259.21 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -6.60
Revenue (TTM): $1.65 M
Dividend Yield: N/A
ROE: -37.54%
Latest News
-
Nektar Therapeutics (NKTR) Presents at UBS Global Biopharma Conference 2026 Transcript
Tue, Nov 17, 2026 10:52 AM
-
Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
Mon, Nov 16, 2026 4:16 PM
Key Financials
Financial data not available